(Q73261735)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Prognostic Significance of CYFRA 21-1 in Patients with Esophageal Squamous Cell Carcinoma (English)

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(02)01905-1

esophageal squamous cell carcinoma

23 December 2023

main subject

1 reference

inferred from title

squamous cell carcinoma

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(02)01905-1

23 December 2023

author name string

Hideaki Shimada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Yoshihiro Nabeya

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Shin-ichi Okazumi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hisahiro Matsubara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Yukimasa Miyazawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Tooru Shiratori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hideki Hayashi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Yoshio Gunji

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Takenori Ochiai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691934

23 December 2023

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

2 November 2019

https://api.elsevier.com/content/article/PII:S1072751502019051?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(02)01905-1

https://api.elsevier.com/content/article/PII:S1072751502019051?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(02)01905-1

https://journals.lww.com/00019464-200304000-00012

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1072-7515(02)01905-1

Journal of the American College of Surgeons

23 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

573-578

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

Studies on the causes of deaths from esophageal carcinoma

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

National Cancer Data Base report on esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Tumor marker expression is predictive of survival in patients with esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Tumor markers carcinoembryonic antigen, CA 50, and CA 19-9 and squamous cell carcinoma of the esophagus. Pretreatment screening

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Serum level of cytokeratin 19 fragment (CYFRA 21-1) indicates tumour stage and prognosis of squamous cell carcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Serum Cyfra 21-1 as a co-variable in future NSCLC chemotherapy trials

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901905-1

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12691934%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference